SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018029
Filing Date
2023-11-07
Accepted
2023-11-07 17:15:48
Documents
85
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20230930x10q.htm   iXBRL 10-Q 2501772
2 EX-10.1 iova-20230930xex10d1.htm EX-10.1 162028
3 EX-10.2 iova-20230930xex10d2.htm EX-10.2 111982
4 EX-31.1 iova-20230930xex31d1.htm EX-31.1 12341
5 EX-31.2 iova-20230930xex31d2.htm EX-31.2 12228
6 EX-32.1 iova-20230930xex32d1.htm EX-32.1 7100
7 EX-32.2 iova-20230930xex32d2.htm EX-32.2 7173
8 GRAPHIC iova-20230930x10q001.jpg GRAPHIC 117091
  Complete submission text file 0001558370-23-018029.txt   10108615

Data Files

Seq Description Document Type Size
9 EX-101.SCH iova-20230930.xsd EX-101.SCH 59793
10 EX-101.CAL iova-20230930_cal.xml EX-101.CAL 55489
11 EX-101.DEF iova-20230930_def.xml EX-101.DEF 270246
12 EX-101.LAB iova-20230930_lab.xml EX-101.LAB 457730
13 EX-101.PRE iova-20230930_pre.xml EX-101.PRE 414733
79 EXTRACTED XBRL INSTANCE DOCUMENT iova-20230930x10q_htm.xml XML 1629417
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 231385097
SIC: 2836 Biological Products, (No Diagnostic Substances)